You are here

Article Text

Article menu
Download PDFPDF
DTB commentary
Evidence for empagliflozin in heart failure with preserved ejection fraction (HFpEF)

Abstract

Commentary on: Anker SD, Butler J, Filippatos G, et al. Empagliflozin in heart failure with a preserved ejection fraction. New England Journal of Medicine, 2021; 385:1451–61.

  • Heart failure
  • Cardiovascular Diseases

https://doi.org/10.1136/dtb.2022.000060

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.